| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |